Moderna Vaccine Had Decade Head Start Over Pfizer: Chairman
November 16, 2020
37,224
375
551
2.49%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Bloomberg Technology Episodes Around November 16, 2020
See what was published immediately before and after this episode.
45:51'Bloomberg Technology' Full Show, Trump TV? Disney Earnings (11/12/2020)
28:23Now PlayingModerna Vaccine Had Decade Head Start Over Pfizer: Chairman
YouTube Description
as posted by the channelNov.16 -- Moderna Inc. reported its Covid-19 vaccine was 94.5% effective in a preliminary analysis of a large late-stage clinical trial. Noubar Afeyan, Moderna co-founder and chairman, discusses the company's new data, distribution, plan for emergency use authorization and its advantage over a vaccine by Pfizer Inc. Afeyan spoke with Bloomberg's Emily Chang.
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.